发明名称 |
FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES |
摘要 |
A formulation, comprising an ophthalmically effective amount of one or more tocotrienol quinones, particularly of alpha-tocotrienol quinone is disclosed. Use of a formulation comprising one or more tocotrienol quinones for the prevention, reduction, amelioration or treatment of ophthalmic disorders that are associated with a neurodegenerative or trauma disorder is also discussed. A method of treating or controlling the ocular symptoms associated with neurodegenerative diseases or trauma with a formulation comprising one or more tocotrienol quinones is also discussed. A method of treating or controlling the ocular symptoms associated with mitochondrial myopathies with a formulation comprising one or more tocotrienol quinones is also discussed. |
申请公布号 |
US2014031433(A1) |
申请公布日期 |
2014.01.30 |
申请号 |
US201313738827 |
申请日期 |
2013.01.10 |
申请人 |
EDISON PHARMACEUTICALS, INC.;EDISON PHARMACEUTICALS, INC. |
发明人 |
MILLER GUY M.;SHRADER WILLIAM D.;KHEIFETS VIKTORIA |
分类号 |
A61K31/122 |
主分类号 |
A61K31/122 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|